The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This study aims at evaluating and comparing the anti-tumor effects of metformin and statins
(hydroxyl-methyl-glutaryl-CoA reductase inhibitors) in patients with non-metastatic breast
cancer (stage I, II, & III).